173 related articles for article (PubMed ID: 14641346)
1. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma.
Kraus S; Miller BH; Swinehart JM; Shavin JS; Georgouras KE; Jenner DA; Griffin E; Korey A; Orenberg EK
J Am Acad Dermatol; 1998 Mar; 38(3):438-42. PubMed ID: 9520026
[TBL] [Abstract][Full Text] [Related]
3. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
4. A patient with squamous cell carcinoma
Vazquez T; Florez-White M
J Dermatolog Treat; 2020 Mar; 31(2):180-182. PubMed ID: 30843746
[No Abstract] [Full Text] [Related]
5. Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil.
Khandpur S; Sharma VK
J Dermatol; 2003 Oct; 30(10):730-4. PubMed ID: 14684956
[TBL] [Abstract][Full Text] [Related]
6. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
7. Intralesional 5-fluorouracil for the treatment of squamous cell carcinomas.
Maxfield L; Shah M; Schwartz C; Tanner LS; Appel J
J Am Acad Dermatol; 2021 Jun; 84(6):1696-1697. PubMed ID: 33378661
[No Abstract] [Full Text] [Related]
8. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
9. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
Tallon B; Turnbull N
Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
[TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil iontophoretic therapy for Bowen's disease.
Welch ML; Grabski WJ; McCollough ML; Skelton HG; Smith KJ; Menon PA; Anderson LL
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):956-8. PubMed ID: 9204062
[TBL] [Abstract][Full Text] [Related]
11. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
Queen D; Trager MH; Fan W; Gordon ER; Samie FH
Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
[TBL] [Abstract][Full Text] [Related]
12. Intralesional 5-Fluorouracil for the Nonsurgical Management of Low-Risk, Invasive Squamous Cell Carcinoma.
Dando EE; Lim GFS; Lim SJM; Kim C; Pugliano-Mauro M
Dermatol Surg; 2020 Jan; 46(1):126-130. PubMed ID: 30608299
[No Abstract] [Full Text] [Related]
13. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged.
Cartei G; Cartei F; Interlandi G; Meneghini G; Jop A; Zingone G; Tabaro G; Mazzoleni F
Am J Clin Oncol; 2000 Apr; 23(2):181-4. PubMed ID: 10776981
[TBL] [Abstract][Full Text] [Related]
14. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach.
Graham BD; Jetmore AB; Foote JE; Arnold LK
Dis Colon Rectum; 2005 Mar; 48(3):444-50. PubMed ID: 15747068
[TBL] [Abstract][Full Text] [Related]
15. Treatment of a giant squamous cell carcinoma on the dominant thumb with intralesional 5-fluorouracil.
Reisinger DM; Cognetta AB; Pynes LT; Paredes AA; Sweeney TJ; Dolson DJ
J Am Acad Dermatol; 2011 Jul; 65(1):219-21. PubMed ID: 21679825
[No Abstract] [Full Text] [Related]
16. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
[TBL] [Abstract][Full Text] [Related]
17. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
Miller BH; Shavin JS; Cognetta A; Taylor RJ; Salasche S; Korey A; Orenberg EK
J Am Acad Dermatol; 1997 Jan; 36(1):72-7. PubMed ID: 8996264
[TBL] [Abstract][Full Text] [Related]
18. Bowen's disease and 5-fluorouracil.
Sturm HM
J Am Acad Dermatol; 1979 Dec; 1(6):513-22. PubMed ID: 528700
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
20. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
